HK172296A - 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol - Google Patents

4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol

Info

Publication number
HK172296A
HK172296A HK172296A HK172296A HK172296A HK 172296 A HK172296 A HK 172296A HK 172296 A HK172296 A HK 172296A HK 172296 A HK172296 A HK 172296A HK 172296 A HK172296 A HK 172296A
Authority
HK
Hong Kong
Prior art keywords
formula
compound
reaction
appropriate
reacting
Prior art date
Application number
HK172296A
Other languages
German (de)
English (en)
French (fr)
Inventor
Antoine Stokbroekx Raymond
Arthur Jules Grauwels Gilbert
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of HK172296A publication Critical patent/HK172296A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Paper (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HK172296A 1991-02-25 1996-09-12 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol HK172296A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65964591A 1991-02-25 1991-02-25
PCT/EP1992/000356 WO1992014731A1 (en) 1991-02-25 1992-02-14 4-[(2-BENZOTHIAZOLYL)METHYLAMINO]-α-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINEETHANOL

Publications (1)

Publication Number Publication Date
HK172296A true HK172296A (en) 1996-09-20

Family

ID=24646210

Family Applications (1)

Application Number Title Priority Date Filing Date
HK172296A HK172296A (en) 1991-02-25 1996-09-12 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol

Country Status (36)

Country Link
US (2) US5434168A (cs)
EP (2) EP0573473B1 (cs)
JP (1) JP2825652B2 (cs)
KR (1) KR0165901B1 (cs)
CN (3) CN1033454C (cs)
AT (1) ATE131478T1 (cs)
AU (1) AU649788B2 (cs)
BG (1) BG62332B1 (cs)
CA (1) CA2104000A1 (cs)
CY (1) CY1924A (cs)
CZ (1) CZ284705B6 (cs)
DE (1) DE69206787T2 (cs)
DK (1) DK0573473T3 (cs)
DZ (1) DZ1560A1 (cs)
EE (1) EE02983B1 (cs)
ES (1) ES2083737T3 (cs)
FI (1) FI933719A7 (cs)
GR (1) GR3018692T3 (cs)
HK (1) HK172296A (cs)
HU (2) HUT67695A (cs)
IE (1) IE69567B1 (cs)
IL (3) IL100952A (cs)
LV (1) LV11689B (cs)
MA (1) MA22447A1 (cs)
MX (1) MX9200777A (cs)
NO (1) NO300591B1 (cs)
NZ (2) NZ248437A (cs)
PL (1) PL168791B1 (cs)
RO (1) RO112959B1 (cs)
RU (2) RU2106348C1 (cs)
SK (1) SK278705B6 (cs)
TN (1) TNSN92017A1 (cs)
TW (1) TW218016B (cs)
WO (1) WO1992014731A1 (cs)
ZA (1) ZA921341B (cs)
ZW (1) ZW1992A1 (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
TW282469B (cs) * 1993-06-11 1996-08-01 Janssen Pharmaceutica Nv
MX9702506A (es) * 1994-10-14 1997-07-31 Janssen Pharmaceutica Nv Suspensiones orales de sabeluzol.
JPH10509712A (ja) * 1994-11-24 1998-09-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ルベルゾール静脈用水剤
WO1996032130A1 (en) * 1995-04-10 1996-10-17 Baxter International Inc. The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
CA2228054A1 (en) * 1995-10-25 1997-05-01 Janssen Pharmaceutica N.V. Lubeluzole n-oxide
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
BR9710002A (pt) * 1996-06-27 1999-08-10 Janssen Pharmaceutica Nv N-[4-(heteroarilmetil)fenil]-heteroarilaminas
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
EP1037632B1 (en) * 1997-11-10 2006-01-11 Bristol-Myers Squibb Company Benzothiazole protein tyrosine kinase inhibitors
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
AU4537500A (en) 1999-05-12 2000-12-05 Neurosearch A/S Ion channel modulating agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963732A (en) * 1973-05-30 1976-06-15 Tiberio Bruzzese Process for preparing dihydroxydiphenylmethane derivatives
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives
US4310658A (en) * 1980-06-18 1982-01-12 Allied Corporation Production of polyester thermally stabilized with an oxirane
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4717760A (en) * 1986-07-10 1988-01-05 The Dow Chemical Company Fluorinated tris-epoxides based on triphenyl methane
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔4,5−b〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
FI933719L (fi) 1993-08-24
FI933719A0 (fi) 1993-08-24
CN1033454C (zh) 1996-12-04
GR3018692T3 (en) 1996-04-30
US5434168A (en) 1995-07-18
ZW1992A1 (en) 1993-09-22
FI933719A7 (fi) 1993-08-24
DE69206787T2 (de) 1996-06-05
EP0573473A1 (en) 1993-12-15
EP0501552A1 (en) 1992-09-02
JPH06505012A (ja) 1994-06-09
DE69206787D1 (de) 1996-01-25
IL113837A (en) 1996-05-14
MA22447A1 (fr) 1992-10-01
HUT67695A (en) 1995-04-28
BG62332B1 (bg) 1999-08-31
CN1117048A (zh) 1996-02-21
CN1043609C (zh) 1999-06-16
PL168791B1 (pl) 1996-04-30
JP2825652B2 (ja) 1998-11-18
CY1924A (en) 1997-03-07
CN1064865A (zh) 1992-09-30
NZ248437A (en) 1994-07-26
EE02983B1 (et) 1997-04-15
IL100952A0 (en) 1992-11-15
WO1992014731A1 (en) 1992-09-03
SK278705B6 (sk) 1998-01-14
ES2083737T3 (es) 1996-04-16
LV11689B (en) 1997-08-20
ZA921341B (en) 1993-08-24
BG98068A (bg) 1994-06-30
DZ1560A1 (fr) 2002-02-17
TW218016B (cs) 1993-12-21
IE920575A1 (en) 1992-08-26
NO933010L (no) 1993-08-24
CN1113437A (zh) 1995-12-20
MX9200777A (es) 1992-08-01
AU1208592A (en) 1992-09-15
RU2106348C1 (ru) 1998-03-10
IL113837A0 (en) 1995-08-31
NZ241592A (en) 1994-07-26
TNSN92017A1 (fr) 1993-06-08
US5675027A (en) 1997-10-07
CA2104000A1 (en) 1992-08-26
NO933010D0 (no) 1993-08-24
HU211560A9 (en) 1995-12-28
EP0573473B1 (en) 1995-12-13
LV11689A (lv) 1997-02-20
RO112959B1 (ro) 1998-02-27
HU9302395D0 (en) 1993-11-29
CS51292A3 (en) 1992-09-16
NO300591B1 (no) 1997-06-23
DK0573473T3 (da) 1996-01-29
CZ284705B6 (cs) 1999-02-17
RU2094434C1 (ru) 1997-10-27
IL100952A (en) 1995-12-31
AU649788B2 (en) 1994-06-02
ATE131478T1 (de) 1995-12-15
IE69567B1 (en) 1996-10-02
KR0165901B1 (en) 1999-01-15
RU95112519A (ru) 1997-04-20

Similar Documents

Publication Publication Date Title
EP0573473B1 (en) 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol
EP0232937B1 (en) Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
US12110285B2 (en) Substituted pyridine derivatives as SARM1 inhibitors
JP2002518380A (ja) サイクリン依存キナーゼの炭素置換アミノチアゾール抑制剤
US4835161A (en) Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
US20020165259A1 (en) Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
EP0378254B1 (en) 2-Aminopyrimidinone derivatives
EP0430334B1 (en) Immunostimulating 6-aryl-5,6-dihydroimidazo[2,1-b]thiazole derivatives
WO1992006086A1 (en) Novel 4-piperidinylcarbonyl derivatives
EP0316820B1 (en) Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
EP0251417B1 (en) 4-(aroylamino) piperidinebutanamide derivatives
US5530011A (en) 4-[(2-benzothiazolyl)methylamino]-α-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)